NFKB1 and cancer: TLR4 ligation by PTX could activate downstream signaling via NF-κB and MAPK that promote pro-inflammatory mediators i.e. IL-6, IL-8, MCP-1, VEGF and XIAP, the functions of which have been reported to enhance cancer progression and drug resistance [9–11].